Viewing StudyNCT00427362



Ignite Creation Date: 2024-05-05 @ 5:18 PM
Last Modification Date: 2024-10-26 @ 9:30 AM
Study NCT ID: NCT00427362
Status: COMPLETED
Last Update Posted: 2008-05-02
First Post: 2007-01-26

Brief Title: A Canadian Open-Label Study to Evaluate the Safety and Effectiveness of Adalimumab When Added to Inadequate Therapy for the Treatment of Psoriatic Arthritis PsA ACCLAIM
Sponsor: Abbott
Organization: Abbott

Conditions & Keywords Data

Conditions:
Name
Psoriatic Arthritis
Keywords: